Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma, Follicular × Furosemide × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 2 Leukemia 2 Brain Neoplasms 2 Urinary Bladder Neoplasms 1 Respiratory Sounds 1 Prostatic Neoplasms 1 Pre-Eclampsia 1 Postoperative Complications 1 Parkinson Disease 1 Neuroendocrine Tumors 1 Neuroblastoma 1 Myelodysplastic Syndromes 1 Musculoskeletal Pain 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Lymphoma 1 Liver Cirrhosis 1 Lewy Body Disease 1 Hypoxia 1 Hodgkin Disease 1 Hemorrhage 1 Edema 1 Dyspnea, Paroxysmal 1 Dyspnea 1 Drug-Related Side Effects and Adverse Reactions 1 Congenital Hyperinsulinism 1 Breast Neoplasms 1 Advanced Solid Malignancies 1

Interventions

Rituximab 257 Cyclophosphamide 214 fludarabine phosphate 93 Peripheral Blood Stem Cell Transplantation 93 Filgrastim 81 Etoposide 75 Radiotherapy 74 Lenalidomide 73 Vincristine 71 Prednisone 71 Doxorubicin 57 Mycophenolic Acid 56 Bendamustine Hydrochloride 55 Whole-Body Irradiation 53 Cyclosporine 51 Melphalan 47 fludarabine 46 obinutuzumab 45 Tacrolimus 43 Cytarabine 42 Busulfan 41 Methotrexate 38 Antilymphocyte Serum 34 Methylprednisolone 32 Bortezomib 31 Carmustine 30 ibritumomab tiuxetan 28 Dexamethasone 28 sargramostim 27 ibrutinib 25

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07167862 2026-01-23

PPPOCUS

University of California, Irvine

Phase 4 Not yet recruiting

Lymphoma, Follicular, Pre-Eclampsia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡